Bharat Book Bureau Provides the Trending Market Research Report on “Global Injectable Drugs Market Research Report (2020-2030) “under Life Sciences category. The Injectable Drugs Market is projected to exhibit highest growth rate over report offers a collection of superior market research, market analysis, and competitive intelligence and industry reports.
Global Injectable Drugs Market will reach $1,037.7 billion by 2030, growing by 9.8% annually over 2020-2030 driven by the increasing prevalence of chronic diseases, rising use of self-administered Injectable formulations, technological advancements in drug development, and growing approvals of new injectable drugs such as COVID-19 vaccines.
Highlighted with 82 tables and 86 figures, this 165-page report “Global Injectable Drugs Market 2020-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery (Pre-filled Syringe, Infusions, Others), Application (Oncology, Infectious Diseases, Autoimmune, Cardiovascular), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global injectable drugs market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).
In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global injectable drugs market in every aspect of the classification from perspectives of Molecule Type, Drug Class, Delivery, Application, Distribution Channel, and Region.
Based on Molecule Type, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
•Small Molecule
•Large Molecule
Based on Drug Class, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
•Monoclonal Antibodies (mAbs)
•Immunoglobulin
•Insulin
•Vaccines
•Cytokines
•Peptide Hormone
•Blood Factors
•Other Drug Classes
Based on Delivery, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
•Pre-filled Syringe
•Infusions
•Other Deliveries
Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
•Oncology
•Infectious Diseases
•Autoimmune Diseases
•Cardiovascular Diseases
•Pain
•Neurology
•Other Applications
Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
•Hospital Pharmacy
•Retail Pharmacy
•E-Commerce
Geographically, the following regions together with the listed national/local markets are fully investigated:
•North America (U.S., Canada, and Mexico)
•Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
•APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
•South America (Brazil, Chile, Argentina, Rest of South America)
•MEA (UAE, Saudi Arabia, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ bn) are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Molecule Type, Drug Class, and Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Amgen Inc.
Baxter International Inc.
Eli Lilly and Company
Gilead Sciences Inc.
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Moderna, Inc.
Novartis AG
Novo Nordisk AS
Pfizer Inc.
Sanofi SA
Teva Pharmaceuticals Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Browse our full report with Table of Contents:
https://bit.ly/3oSwhvw
About Us
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 15,00,000 reports and insights that includes latest Industry Study, Industry Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]
Website: www.bharatbook.com
Transparency Market Research (TMR) has published a new report titled, “Lyophilized Injectable Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.
Based on end-user, the market has been categorized into hospitals, ambulatory surgical centers, specialty clinics, and others.
In terms of type of packaging, the single-use vials segment dominated the global market in 2017.
Request Customization on Lyophilized Injectable Drugs Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=37799 North America Dominated Global MarketNorth America was the leading market for lyophilized injectable drugs in 2017 primarily due to extensive research & development activities, rapid acceptance of innovative technologies, and significant investments toward the development of health care infrastructure.
Additionally, presence of large number of manufacturing facilities in North America makes it the largest market for lyophilized injectable drugs.
Asia Pacific presents significant opportunities in the health care sector, and was the third largest market in 2017.
